Avalo Therapeutics (AVTX) Inventory (2017 - 2023)
Avalo Therapeutics (AVTX) reported Inventory of $18000.0 for Q2 2023, down 21.74% on a YoY basis from $23000.0 in Q2 2022, and down 5.26% quarter-over-quarter from $19000.0 in Q1 2023.
Avalo Therapeutics (AVTX) Inventory (2017 - 2023) Analysis & Trends
Avalo Therapeutics has reported Inventory for 7 years, with the latest figure at $18000.0 in Q2 2023.
- For the quarter ending Q2 2023, Inventory fell 21.74% year-over-year to $18000.0; the trailing twelve-month figure through Jun 2023 stood at $18000.0 (down 21.74% YoY), and the FY2022 full-year result was $20000.0, down 47.37% from the prior year.
- Inventory for Q2 2023 stood at $18000.0, down from $19000.0 in the prior quarter.
- The five-year high for Inventory was $1.0 million in Q1 2019, with the low at $3000.0 in Q4 2020.
- Historically, Inventory has averaged $107007.2 across 5 years, with a median of $20000.0 in 2021.
- Annual changes were most pronounced in 2020 — Inventory slumped 98.45% — and 2021, when it jumped 1166.67%.
- Avalo Therapeutics' Inventory stood at $21334.0 in 2019, then plunged by 85.94% to $3000.0 in 2020, then jumped by 1166.67% to $38000.0 in 2021, then slumped by 47.37% to $20000.0 in 2022, then declined by 10.0% to $18000.0 in 2023.
- The last three Inventory figures came in at $18000.0 (Q2 2023), $19000.0 (Q1 2023), and $20000.0 (Q4 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 32.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.77 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Avalo Therapeutics | 295.77 Mn | 295.77 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 18,000.00 |
| Mar 31, 2023 | 19,000.00 |
| Dec 31, 2022 | 20,000.00 |
| Sep 30, 2022 | 22,000.00 |
| Jun 30, 2022 | 23,000.00 |
| Mar 31, 2022 | 25,000.00 |
| Dec 31, 2021 | 38,000.00 |
| Sep 30, 2021 | 16,000.00 |
| Jun 30, 2021 | 20,000.00 |
| Dec 31, 2020 | 3,000.00 |
| Sep 30, 2020 | 9,060.00 |
| Jun 30, 2020 | 12,196.00 |
| Mar 31, 2020 | 16,276.00 |
| Dec 31, 2019 | 21,334.00 |
| Sep 30, 2019 | 402,267.00 |
| Mar 31, 2019 | 1.05 Mn |
| Dec 31, 2018 | 317,923.00 |
| Sep 30, 2018 | 1.06 Mn |
| Jun 30, 2018 | 1.54 Mn |
| Mar 31, 2018 | 3.44 Mn |